National Comprehensive Cancer Network



About NCCN

Kidney/Testicular Cancers Panel - Disclosures as of 8/6/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Neeraj Agarwal, MD

None

None

None

None

8/3/2012

Clair Beard, MD

None

None

None

None

5/3/2013

Sam Bhayani, MD

None

None

None

None

8/19/2012

Graeme B. Bolger, MD

None

Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Wyeth Pharmaceuticals

None

None

3/5/2013

Michael A. Carducci, MD

None

AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
Boehringer Ingelheim GmbH;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Astellas;
Kinex;
Pfizer Inc.;
sanofi-aventis U.S.;
Takeda Pharmaceuticals North America, Inc.

None

None

10/12/2011

Sam S. Chang, MD

None

None

None

None

8/6/2012

Toni K. Choueiri, MD

None

Bayer HealthCare;
Bayer HealthCare;
Genentech, Inc.;
GlaxoSmithKline;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.;
Agennix;
Pfizer Inc.

None

None

10/1/2012

Mary Dwyer, MS

None

None

None

None

3/26/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Hans-Joerg Hammers, MD, PhD

None

None

None

None

8/5/2011

Steven L. Hancock, MD

None

None

None

None

1/26/2012

Gary R. Hudes, MD

None

Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Wyeth Pharmaceuticals

None

None

12/6/2011

Eric Jonasch, MD

None

Bayer HealthCare;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

10/6/2012

David Josephson, MD

Intuitive Surgical, Inc.

Intuitive Surgical, Inc.

None

None

7/13/2010

Rashmi Kumar, PhD

None

None

None

None

2/15/2012

Ellis G. Levine, MD

None

None

None

None

8/15/2012

Daniel W. Lin, MD

None

None

None

None

4/8/2012

Kim A. Margolin, MD

None

None

None

None

4/3/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

M. Dror Michaelson, MD, PhD

None

Genentech, Inc.;
Pfizer Inc.;
Wyeth Pharmaceuticals

None

None

8/7/2012

Robert J. Motzer, MD

None

Eisai Inc.

None

None

12/14/2011

Thomas Olencki, DO

None

Genentech, Inc.

None

None

3/4/2013

Roberto Pili, MD

Pfizer Inc.

Genentech, Inc.;
Genentech, Inc.;
Pfizer Inc.;
Pfizer Inc.;
Wyeth Pharmaceuticals;
Wyeth Pharmaceuticals

None

None

4/12/2013

Thomas W. Ratliff, MD

None

Bayer HealthCare;
GlaxoSmithKline

None

None

7/1/2011

Bruce G. Redman, DO

None

None

None

None

8/6/2012

Cary N. Robertson, MD

None

EDAP TMS, Inc.;
EUSA

None

None

8/8/2011

Charles J. Ryan, MD

None

None

None

None

6/10/2011

Joel Sheinfeld, MD

None

None

None

None

8/7/2012

Philippe E. Spiess, MD

None

None

None

None

4/29/2013

Jue Wang, MD

None

None

None

None

9/7/2012

Richard B. Wilder, MD

None

None

None

None

8/6/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved